← Leaderboards
Thai Huu Ho
Mayo Clinic Rochester
$2,233,050
Attributed
$4,466,099
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $577.6K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,466,099 · 2
By mechanism
R01$4,466,099 · 2
Top collaborators
- Keith D Robertson8 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Keith D Robertson$11,241,926
- Shruthi Naik$1,310,428
- Tait D Shanafelt$9,008,119
- Stephen Norman Thibodeau$86,704,246
- Anne Josephine Novak$1,635,254
Others in their field
Other Emerging Leaders on “Genome-Wide”
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Lynn Briscoe · Leidos Biomedical Research, Inc.$24,306,947
- Badri N Vardarajan · University Of Miami School Of Medicine$20,206,265
- Brian William Kunkle · University Of Miami School Of Medicine$13,466,231
- Leonard Freedmand · Leidos Biomedical Research, Inc.$11,639,100
- Jacqueline K White · Jackson Laboratory$11,525,170
Research focus
Genome-WideMediatingEpigenomeGenesLinkMalignant NeoplasmsDrug TargetingEpigenetic ProcessGene ExpressionCancer EtiologyHistonesIn VivoLysineCell GrowthAffectDna MethylationCellsEnhancersCessation Of LifeFrequenciesChromatinClear Cell Renal Cell CarcinomaHistone H3Methylation
Grant awards (8)
Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma$539,540
R01 · FY2025 · CA
Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma$512,562
R01 · FY2024 · CA
Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma$554,891
R01 · FY2023 · CA
Deciphering the interplay between H3K36 and DNA methylation in renal cancer$566,045
R01 · FY2022 · CA
Deciphering the interplay between H3K36 and DNA methylation in renal cancer$577,597
R01 · FY2021 · CA
Deciphering the interplay between H3K36 and DNA methylation in renal cancer$577,597
R01 · FY2020 · CA
Deciphering the interplay between H3K36 and DNA methylation in renal cancer$560,270
R01 · FY2019 · CA
Deciphering the interplay between H3K36 and DNA methylation in renal cancer$577,597
R01 · FY2018 · CA